Form 8-K PALVELLA THERAPEUTICS, For: Dec 15
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/2/2026
- Wall Street ends lower as higher yields, rising oil prices mark shaky start to September
- Oil prices jump 4% as fresh US-Iran fighting stokes supply fears
- Two Saudi tankers struck in Strait of Hormuz Monday
- Dell again lifts annual forecasts as AI demand powers record results
- Fed’s Barr backs rate hike if inflation fails to cool, September odds hit 66%
- GoPro to merge with Starman Optical in $285M recapitalization deal
- GoPro (GPRO) Halted, News Pending
- Wall Street ends lower as higher yields, rising oil prices mark shaky start to September
- Gap taps Coach architect Reed Krakoff for $29.95-$498 handbag line
- S&P Global shares rise on report of possible CapIQ spinoff
Palvella Therapeutics (PVLA) PT Raised to $190 at Truist Securities
December 15, 2025 2:14 PM ESTTruist Securities analyst Danielle Brill raised the price target on Palvella Therapeutics (NASDAQ: PVLA) to $190.00 (from $105.00) while maintaining a Buy rating.
The analyst comments "We incorporated risk adjusted sales for cutaneous venous malformations (CVM) into our PVLA model which raises our PT to $190 (from... More
Palvella Therapeutics (PVLA) PT Raised to $210 at Cantor Fitzgerald
December 15, 2025 10:09 AM ESTCantor Fitzgerald analyst Josh Schimmer raised the price target on Palvella Therapeutics (NASDAQ: PVLA) to $210.00 (from $200.00) while maintaining a Overweight rating.
... More